Elena Shagisultanova retweeted
No difference in recurrence among DCIS pts taking anastrozole or tamoxifen the.aacr.org/Qw2 #SABCS15
#aacr #sabcs #SABCSchat
KEYNOTE study: pembrolizumab in ER+/HER2- cancer RR 12%, clinical benefit 20% - combination immunotherapy needed
2
#aacr #sabcs15 #sabcschat
Dear patients, do not smoke! Risk of lung cancer in a smoker after breast RT goes up (9.4 to 13.8%) - EBCTCG study
#aacr #scbcschat #sabcs15
Very interesting cell lines and mice data that PDK1 inhibition synergizes with CDK4/6 inhibition Poster # PD2-06
TMA analysis of blocks from DBCG77B trial - luminal A patients may not benefit from chemo? To be reconciled with upcoming RxSPONDER results
1
#aacr #sabcschat #sabcs15
More MANTICORE slides - patients on beta-blockers had less interruptions of herceptin
1
#sabcschat #sabcs15 #aacr
Results of MANTICORE randomized trial (beta blockers prevent LV dysfunction on Herceptin)
1
#sabcschat #sabcs15 #aacr
SWOG-8814 retrospective analysis is not enough to use Oncotype in ER+ LN+ pnt, will await RxSPONDER results 2016
#sabcschat #sabcs15 #aacr
Dr. Hayes (Univ. of Michigan): no evidence to withhold chemo in HR+ lymph node + patient with low Oncotype score
#aacr #sabcschat
Great efforts from ENIGMA consortium: enigmaconsortium.org/ - classifying breast cancer risk associated with various VUS.
1
#sabcschat #aacr
Now I will refer all my patients with VUS to PROMT registry promptinfo.squarespace.com/a… - helping to reclassify VUS!
1
#sabcschat #aacr
Excellent session on hereditary predisposition to breast cancer by Domchek, Robson and Couch!
#sabcschat #aacr Going to San Antonio Breast Cancer symposium tomorrow - very excited about it!
2




